BIOMAT Database Logo BIOMAT Database Logo

Propranolol and hydrallazine in the management of essential hypertension in pregnancy. 1980

G Bott-Kanner, and A Schweitzer, and S H Reisner, and S J Joel-Cohen, and J B Rosenfeld

A combination of propranolol and hydrallazine was administered to 13 patients with longstanding hypertension during 15 pregnancies. Hydrallazine was continued through labour and delivery in all patients, while in eight patients propranolol was discontinued 2 to 15 days before delivery. Blood pressure control was uniformly good and superimposed pre-eclampsia did not occur during combined therapy. There were 14 livebirths and one unexplained stillbirth. Except for two cases of milk hypoglycemia, there were no neonatal complications.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007003 Hypoglycemia A syndrome of abnormally low BLOOD GLUCOSE level. Clinical hypoglycemia has diverse etiologies. Severe hypoglycemia eventually lead to glucose deprivation of the CENTRAL NERVOUS SYSTEM resulting in HUNGER; SWEATING; PARESTHESIA; impaired mental function; SEIZURES; COMA; and even DEATH. Fasting Hypoglycemia,Postabsorptive Hypoglycemia,Postprandial Hypoglycemia,Reactive Hypoglycemia,Hypoglycemia, Fasting,Hypoglycemia, Postabsorptive,Hypoglycemia, Postprandial,Hypoglycemia, Reactive
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007232 Infant, Newborn, Diseases Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts. Neonatal Diseases,Disease, Neonatal,Diseases, Neonatal,Neonatal Disease
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011249 Pregnancy Complications, Cardiovascular The co-occurrence of pregnancy and a cardiovascular disease. The disease may precede or follow FERTILIZATION and it may or may not have a deleterious effect on the pregnant woman or FETUS. Cardiovascular Pregnancy Complications,Complications, Cardiovascular Pregnancy,Pregnancy, Cardiovascular Complications,Cardiovascular Pregnancy Complication,Complication, Cardiovascular Pregnancy,Pregnancies, Cardiovascular Complications,Pregnancy Complication, Cardiovascular
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

G Bott-Kanner, and A Schweitzer, and S H Reisner, and S J Joel-Cohen, and J B Rosenfeld
Comparison of labetalol, hydrallazine, and propranolol in the therapy of moderate hypertension.
March 1980, The Medical journal of Australia,
G Bott-Kanner, and A Schweitzer, and S H Reisner, and S J Joel-Cohen, and J B Rosenfeld
Management of pregnancy in essential hypertension.
July 1955, The Journal of the Arkansas Medical Society,
G Bott-Kanner, and A Schweitzer, and S H Reisner, and S J Joel-Cohen, and J B Rosenfeld
The management of essential hypertension during pregnancy.
October 1979, Clinical cardiology,
G Bott-Kanner, and A Schweitzer, and S H Reisner, and S J Joel-Cohen, and J B Rosenfeld
Verapamil and propranolol in essential hypertension.
December 1984, Clinical pharmacology and therapeutics,
G Bott-Kanner, and A Schweitzer, and S H Reisner, and S J Joel-Cohen, and J B Rosenfeld
Propranolol therapy in essential hypertension.
May 1972, American heart journal,
G Bott-Kanner, and A Schweitzer, and S H Reisner, and S J Joel-Cohen, and J B Rosenfeld
The essential action of propranolol in hypertension.
May 1976, The American journal of medicine,
G Bott-Kanner, and A Schweitzer, and S H Reisner, and S J Joel-Cohen, and J B Rosenfeld
Propranolol in the treatment of essential hypertension.
May 1977, JAMA,
G Bott-Kanner, and A Schweitzer, and S H Reisner, and S J Joel-Cohen, and J B Rosenfeld
Sympathetic reflex responses during treatment of essential hypertension with hydrallazine and oxprenolol.
July 1979, British journal of clinical pharmacology,
G Bott-Kanner, and A Schweitzer, and S H Reisner, and S J Joel-Cohen, and J B Rosenfeld
Propranolol and tienilic acid in essential hypertension.
January 1979, Postgraduate medical journal,
G Bott-Kanner, and A Schweitzer, and S H Reisner, and S J Joel-Cohen, and J B Rosenfeld
Propranolol-hydrochlorothiazide combination in essential hypertension.
January 1982, Clinical therapeutics,
Copied contents to your clipboard!